These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 6979570

  • 1. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
    Jayawardena AN, Murphy DB, Janeway CA, Gershon RK.
    J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
    [Abstract] [Full Text] [Related]

  • 2. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.
    Vinetz JM, Kumar S, Good MF, Fowlkes BJ, Berzofsky JA, Miller LH.
    J Immunol; 1990 Feb 01; 144(3):1069-74. PubMed ID: 1967271
    [Abstract] [Full Text] [Related]

  • 3. Cellular subsets involved in cell-mediated immunity to murine Plasmodium yoelii 17X malaria.
    Mogil RJ, Patton CL, Green DR.
    J Immunol; 1987 Mar 15; 138(6):1933-9. PubMed ID: 3102605
    [Abstract] [Full Text] [Related]

  • 4. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
    Brake DA, Weidanz WP, Long CA.
    J Immunol; 1986 Jul 01; 137(1):347-52. PubMed ID: 2423609
    [Abstract] [Full Text] [Related]

  • 5. Experimental malaria in the CBA/N mouse.
    Jayawardena AN, Janeway CA, Kemp JD.
    J Immunol; 1979 Dec 01; 123(6):2532-9. PubMed ID: 387872
    [Abstract] [Full Text] [Related]

  • 6. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep 01; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan 01; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 8. The immunological response of CBA mice to P. yoelii. II. The passive transfer of immunity with serum and cells.
    Jayawardena AN, Targett GA, Leuchars E, Davies AJ.
    Immunology; 1978 Jan 01; 34(1):157-65. PubMed ID: 342396
    [Abstract] [Full Text] [Related]

  • 9. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G, Titus RG, Cerottini JC, Marchal G, Louis JA.
    J Immunol; 1986 Feb 15; 136(4):1467-71. PubMed ID: 2418115
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors.
    Barry RA, Hinrichs DJ.
    Clin Invest Med; 1984 Feb 15; 7(4):303-9. PubMed ID: 6442653
    [Abstract] [Full Text] [Related]

  • 11. Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.
    Kumar S, Good MF, Dontfraid F, Vinetz JM, Miller LH.
    J Immunol; 1989 Sep 15; 143(6):2017-23. PubMed ID: 2570802
    [Abstract] [Full Text] [Related]

  • 12. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1982 Apr 15; 128(4):1917-22. PubMed ID: 6120976
    [Abstract] [Full Text] [Related]

  • 13. Adoptive transfer of immunity to Plasmodium berghei with spleen cells from drug cured mice.
    Yadav M, Sidhu AS.
    Southeast Asian J Trop Med Public Health; 1982 Jun 15; 13(2):186-95. PubMed ID: 6755741
    [Abstract] [Full Text] [Related]

  • 14. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H, Kato K, Meade R, Green DR, Horowitz M, Ptak W, Askenase PW.
    J Immunol; 1984 Nov 15; 133(5):2402-11. PubMed ID: 6332850
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep 15; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 16. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK, Weerasinghe A, Halder RC, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T.
    Cell Immunol; 2001 Aug 01; 211(2):96-104. PubMed ID: 11591113
    [Abstract] [Full Text] [Related]

  • 17. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis.
    Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW.
    J Immunol; 1986 Jul 01; 137(1):341-6. PubMed ID: 3486915
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL, Scott PA, Asofsky R, Sher FA.
    J Immunol; 1984 Apr 01; 132(4):2072-7. PubMed ID: 6230400
    [Abstract] [Full Text] [Related]

  • 19. Cellular interactions in the adoptive transfer of contact sensitivity: characterization of an antigen-nonspecific Vicia villosa-adherent T cell needed for adoptive transfer into naive recipients.
    Ptak W, Green DR, Flood P.
    J Immunol; 1986 Sep 15; 137(6):1822-8. PubMed ID: 2943803
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S, Fujiwara H, Yamane Y, Sano S, Nakajima H, Izumi Y, Arai H, Kawanishi Y, Tsuchida T, Hamaoka T.
    Jpn J Cancer Res; 1986 Feb 15; 77(2):182-9. PubMed ID: 3082830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.